chr14-88824709-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_144596.4(TTC8):āc.2T>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,606,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_144596.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000429 AC: 1AN: 232976Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 127434
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1454278Hom.: 0 Cov.: 31 AF XY: 0.00000692 AC XY: 5AN XY: 722790
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74316
ClinVar
Submissions by phenotype
TTC8-related disorder Uncertain:1
The TTC8 c.2T>G variant is predicted to disrupt the translation initiation site (Start Loss). To our knowledge, this variant, or other start-loss variants, have not been reported in the literature in patients with TTC8-related disorders. This variant is reported in 0.0017% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Of note, an additional methionine residue resides four amino acids downstream. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at